Skip to content

Earnings yield at other companies

Pfizer logo
PfizerPFE
6.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-13.3%-888pp
Replimune Group logo
Replimune GroupREPL
-41.3%+90.2pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-4.8%-2.1pp
Erasca, Inc. logo
Erasca, Inc.ERAS
-5.5%-2.6pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-13.6%-5.7pp

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Calculated from OnKure Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s earnings yield?
OnKure Therapeutics, Inc. (OKUR) reported earnings yield of -33% in Q1 2026.
How has OnKure Therapeutics, Inc.'s earnings yield changed year-over-year?
OnKure Therapeutics, Inc.'s earnings yield decreased by 1.5% year-over-year, from -32.5% to -33%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.